Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates Journal Article

   

Authors:	King, D. A.; Smith, A. R.; Pineda, G.; Nakano, M.; Michelini, F.; Goedegebuure, S. P.; Thyparambil, S.; Liao, W. L.; McCormick, A.; Ju, J. H.; Cioffi, M.; Zhang, X.; Hundal, J.; Griffith, M.; Grandori, C.; Pollastro, M.; Rosati, R.; Margossian, A.; Chatterjee, P.; Ainge, T.; Flory, M.; Ocampo, P.; Chen, L. M.; Poultsides, G. A.; Baron, A. D.; Chang, D. T.; Herman, J. M.; Gillanders, W. E.; Park, H.; Hoos, W. A.; Nichols, M.; Fisher, G. A.; Kuo, C. J.
Article Title:	Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates
Keywords:	gemcitabine; trastuzumab; expression; combination; gastric-cancer; herceptin
Journal Title:	JCO Precision Oncology
Volume:	7
ISSN:	2473-4284
Publisher:	American Society of Clinical Oncology
Date Published:	2023-09-01
Start Page:	e2100489
Language:	English
ACCESSION:	WOS:001197689200095
DOI:	10.1200/po.21.00489
PROVIDER:	wos
PMCID:	PMC10309581
PUBMED:	37079860
Notes:	Article -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/216489